| 000 | 01327 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513132821.0 | ||
| 264 | 0 | _c19980115 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/s0041-1345(97)00849-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, D O | |
| 245 | 0 | 0 |
_aAntilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cDec 1997 |
||
| 300 |
_a13S-15S p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xtherapeutic use |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aKfoury, A G | |
| 700 | 1 | _aPisani, B | |
| 700 | 1 | _aHammond, E H | |
| 700 | 1 | _aRenlund, D G | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 29 _gno. 8A _gp. 13S-15S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-1345(97)00849-x _zAvailable from publisher's website |
| 999 |
_c9384246 _d9384246 |
||